Literature DB >> 22638617

Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy.

Chui Ming Gemmy Cheung1, Mayuri Bhargava, Li Xiang, Ranjana Mathur, Chan Choi Mun, Doric Wong, Tien Yin Wong.   

Abstract

BACKGROUND: To determine clinical or imaging prognostic features for visual outcome in eyes with submacular hemorrhage secondary to age-related macular degeneration (AMD) or polypoidal choroidal vasculopathy (PCV).
METHODS: A prospective case series of 11 eyes from 11 patients with submacular hemorrhage secondary to AMD or PCV. All participants had measurement of clinical characteristics, fundus angiogram, and indocyanine green angiography, spectral domain optical coherence tomography (OCT, Cirrus, Zeiss) at baseline and 6 months.
RESULTS: Median visual acuity improved from 20/132 to 20/63 at month 6. The median improvement in vision was 0.20 LogMAR units. Proportion of eyes with best-corrected visual acuity (BCVA) ≥ 1.0 increased from 6/11 (54.5 %) at baseline to 8/11 (72.7 %) at month 6. Eyes with BCVA > 1.0 were more likely to have larger area of hemorrhage and thinner subfoveal neurosensory retinal thickness at baseline and at month 6.
CONCLUSIONS: Thinner neurosensory retina demonstrated on OCT at baseline may be a useful prognostic sign for limited visual recovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22638617     DOI: 10.1007/s00417-012-2029-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  26 in total

1.  Autofluorescence and retinal pigment epithelial atrophy after subretinal hemorrhage.

Authors:  Miki Sawa; Michael D Ober; Richard F Spaide
Journal:  Retina       Date:  2006-01       Impact factor: 4.256

2.  Evolving strategies in the management of submacular hemorrhage associated with choroidal neovascularization in the anti-vascular endothelial growth factor era.

Authors:  Bozho Todorich; Ingrid U Scott; Harry W Flynn; Mark W Johnson
Journal:  Retina       Date:  2011-10       Impact factor: 4.256

3.  Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Authors:  David M Brown; Peter K Kaiser; Mark Michels; Gisele Soubrane; Jeffrey S Heier; Robert Y Kim; Judy P Sy; Susan Schneider
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

4.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

5.  Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.

Authors:  Wai-Man Chan; David T L Liu; Timothy Y Y Lai; Haitao Li; Jian-Ping Tong; Dennis S C Lam
Journal:  Clin Exp Ophthalmol       Date:  2005-12       Impact factor: 4.207

6.  Fibrin directs early retinal damage after experimental subretinal hemorrhage.

Authors:  C A Toth; L S Morse; L M Hjelmeland; M B Landers
Journal:  Arch Ophthalmol       Date:  1991-05

7.  Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration.

Authors:  J F Vander; J L Federman; C Greven; M M Slusher; V P Gabel
Journal:  Ophthalmology       Date:  1991-01       Impact factor: 12.079

8.  Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration.

Authors:  Margaret A Chang; Diana V Do; Susan B Bressler; Sandra D Cassard; Emily W Gower; Neil M Bressler
Journal:  Retina       Date:  2010-09       Impact factor: 4.256

9.  Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.

Authors:  Claudia Kuhli-Hattenbach; Ina Barbara Fischer; Rainer Schalnus; Lars-Olof Hattenbach
Journal:  Am J Ophthalmol       Date:  2009-11-24       Impact factor: 5.258

10.  Hemoglobin-induced lipid peroxidation in the retina: a possible mechanism for macular degeneration.

Authors:  T Ito; M Nakano; Y Yamamoto; T Hiramitsu; Y Mizuno
Journal:  Arch Biochem Biophys       Date:  1995-02-01       Impact factor: 4.013

View more
  9 in total

1.  Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.

Authors:  Jae Hui Kim; Young Suk Chang; Dong Won Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Jpn J Ophthalmol       Date:  2017-11-29       Impact factor: 2.447

2.  Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome.

Authors:  Young Suk Chang; Jae Hui Kim; Jong Woo Kim; Tae Gon Lee; Chul Gu Kim; Sung Won Cho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-19       Impact factor: 3.117

3.  Radiating hemorrhage in exudative age-related macular degeneration.

Authors:  Jae Hui Kim; Young Suk Chang; Jong Woo Kim; Tae Gon Lee; Chul Gu Kim; Dong Won Lee
Journal:  Jpn J Ophthalmol       Date:  2016-07-25       Impact factor: 2.447

4.  Systemic, Ocular and Genetic Risk Factors for Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Singaporeans.

Authors:  Chui Ming Gemmy Cheung; Augustinus Laude; Ian Yeo; Shu-Pei Tan; Qiao Fan; Ranjana Mathur; Shu Yen Lee; Choi Mun Chan; Gavin Tan; Tock Han Lim; Ching-Yu Cheng; Tien Yin Wong
Journal:  Sci Rep       Date:  2017-01-25       Impact factor: 4.379

5.  Plasma lipoprotein subfraction concentrations are associated with lipid metabolism and age-related macular degeneration.

Authors:  Chui Ming Gemmy Cheung; Alfred Gan; Qiao Fan; Miao Ling Chee; Rajendra S Apte; Chiea Chuen Khor; Ian Yeo; Ranjana Mathur; Ching-Yu Cheng; Tien Yin Wong; E Shyong Tai
Journal:  J Lipid Res       Date:  2017-07-11       Impact factor: 5.922

6.  Choroidal Remodeling in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-month Prospective Study.

Authors:  Daniel Shu Wei Ting; Yasuo Yanagi; Rupesh Agrawal; Hwei Yee Teo; Sophia Seen; Ian Yew San Yeo; Ranjana Mathur; Choi Mun Chan; Shu Yen Lee; Edmund Yick Mun Wong; Doric Wong; Tien Yin Wong; Gemmy Chui Ming Cheung
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

Review 7.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

8.  Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm.

Authors:  Yasmin Ali Said; Evelien Dewilde; Peter Stalmans
Journal:  J Ophthalmol       Date:  2021-12-30       Impact factor: 1.909

9.  A prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Chui Ming Gemmy Cheung; Xiang Li; Ranjana Mathur; Shu Yen Lee; Choi Mun Chan; Ian Yeo; Boon Kwang Loh; Rachel Williams; Edmund Yick-Mun Wong; Doric Wong; Tien Yin Wong
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.